News
Upperton Pharma Solutions is a winner in the Business Expansion category in the 2025 Pharmaceutical Excellence Awards.
Philadelphia-based biotech Vivodyne has raised $40 million in series A funding to advance its fully robotic, AI-powered ...
Onesource Specialty, a newly demerged pharma CDMO, is set to benefit from the $150 billion GLP-1 weight-loss drug boom with ...
The pharmaceutical company is evaluating all options to increase its presence in therapy areas, including in-licensing ...
As geopolitical tensions prompt global pharmaceutical giants to pivot away from China, India's Contract Development and ...
The European Commission plans to create a public-private fund of at least 10 billion euros ($11.3 billion) to help tech ...
Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics ...
The company will engage in BIO One-on-One Partnering™ meetings as it advances Phase 1 for Ketamir-2, prepares Phase IIa study in neuropathic pain, and finalizes filings for SKNY acquisition.
Data compiled by fund manager Aberdeen and broker Peel Hunt show 61 firms, worth a combined £12.3bn, have announced plans to ...
Company Has Initiated FINRA Process to Complete Rebranding and Ticker Update NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bionoid Pharma, Inc. (OTC PINK:BINP) ("Bionoid" or the "Company") is ...
The company licenses the patented and ... Up Tunable High-Frequency Microwave Heating for Pharmaceutical and Biologics Manufacturing.” It aims to build the core knowledge needed to successfully scale ...
2don MSNOpinion
They will tell you they invested heavily in evidence-based approaches and programs for teaching reading—the “science of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results